Skip to main content
Equibles
AEMD logo

AEMD · Aethlon Medical Inc · Metrics

Track AEMD — free

Use AEMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AEMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.45 -0.18 (-2.71%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — cleared Aug 13, 2026

The latest filing no longer states the doubt (first flagged Jun 10, 2026).

View the 10-Q filed Aug 13, 2026
Market Cap
$4.54M
Shares
711,136
Volume · Oct 2 40.93K Avg daily vol (43 sessions) 3.79M

AEMD metrics

40 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.45
Market cap
$4.54M

Price action

20 metrics
Price change (1W)
+2.7%
Price change (30D)
+254.4%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
70.7
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
3.79M
Relative volume
0.0
Average dollar volume
$18.99M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
711,136

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.9×
reciprocal yield 12.6%
P / book
0.9
reciprocal yield 114.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-152.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$7.08M
Net income (TTM)
−$6.94M
Trailing 12 months
Diluted EPS (TTM)
$-14.65
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$77.78

Growth

11 metrics
Revenue growth YoY
+4,278.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$574,245
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+826.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-133.4%
Return on assets
-111.3%
Debt / equity
—
Current ratio
5.4
EBITDA (TTM)
−$6.77M
Free cash flow (TTM)
—
Quick ratio
5.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$4.93M
Latest balance sheet
Cash & equivalents
$4.93M
Total assets
$6.24M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.18M
Capital expenditures (TTM)
$12,854
R&D (TTM)
$1.94M
SG&A (TTM)
—
Stock compensation (TTM)
$256,105
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
17
13F filer change QoQ
+5
Institutional ownership
7.5%

Short interest

3 metrics
Short interest
10.5%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 882291 CUSIP 00808Y703 Visit website Investor relations